Therapeutic options to treat the common cancer hepatocellular carcinoma are limited and new treatments are therefore required. Radioembolization with iodine-131 or rhenium-188 labeled lipiodol, or with yttrium-90 labeled microspheres is a promising approach. Jean-Luc Raoul and coauthors discuss the different radionuclides and delivery vehicles used, the clinical trial data and the future perspectives for radioembolization.
- Jean-Luc Raoul
- Eveline Boucher
- Etienne Garin
